Official announcements
Safety warnings
|
messages in brief
|
23/03/2017
EpiPen 300 micrograms solution for injection in a ready-to-use pen (epinephrine) has been approved under the MRP/DCP procedure since March 30, 1998 for the emergency treatment of severe allergic reactions (anaphylaxis) to e.g. insect stings or bites,…
Safety warnings
|
Medicines
|
23/03/2017
Worldwide, there were two complaints outside of Austria that the auto-injector did not work correctly. Meda Pharma GmbH is therefore recalling a batch of EpiPen 300 micrograms in Austria.
Recall
|
Medicines
|
23/03/2017
The marketing authorization holder informed its supplied customers in a letter dated March 23, 2017, that there is a very low probability that the auto-injector of batch 5FA665N does not work correctly. Worldwide, there were two customer complaints…
messages in brief
|
16/03/2017
Swissmedic , the Swiss Agency for Therapeutic Products, wants to work more closely with its partner authority in Austria. Swissmedic Director Jürg H. Schnetzer and Christa Wirthumer-Hoche, Business Unit Head of Medical Market Surveillance at the…
Safety warnings
|
messages in brief
|
06/03/2017
Due to current events (see screenshot), the Federal Office for Safety in Health Care points out that according to §59 of the Medicines Act, private individuals are prohibited from offering medicines privately for sale to other persons or from trading…
Recall
|
Veterinary Medicines
|
01/03/2017
The marketing authorization holder has informed its supplied customers by letter dated 01.03.2017 that above mentioned batches of "Vetofol 10 mg/ml Emulsion for Injection for Dogs and Cats" are recalled. In individual bottles, parts may come off the…
Recall
|
Medicines
|
23/02/2017
The marketing authorization holder has informed its supplied customers in a letter dated 22.2.2017 that a possible contamination with another active ingredient has been discovered at the manufacturer. For this reason, a recall of the above-mentioned…
messages in brief
|
21/02/2017
Since toxic pyrrolizidine alkaloids (PAs) were detected in high concentrations in herbal medicinal products produced from plants that do not biosynthesize PAs themselves, in March 2016 BASG published risk-minimizing measures that were to be…
Safety warnings
|
messages in brief
|
30/01/2017
New recommendations for levonorgestrel emergency contraceptives in case of interactions with CYP3A4-inducing drugs. In Austria, the current recommendations of the European Medicines Agency are being implemented following a technical review of…
messages in brief
|
23/01/2017
Information on user registration and submission of sales and delivery notifications as well as ways to contact us can be found here . Please note the deadline for submission by the end of March 2017.